Frank Neumann
Corporate Officer/Principal presso KITE PHARMA INC
Profilo
Frank Neumann is currently the Head-Clinical Development at Kite Pharma, Inc. He was previously the Vice President & Head-Oncology Clinical Research at bluebird bio, Inc. and the Chief Medical Officer at Verastem, Inc. He holds a doctorate degree from the University of Bonn and Heinrich-Heine-Universität Düsseldorf.
Posizioni attive di Frank Neumann
| Società | Posizione | Inizio |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di Frank Neumann
| Società | Posizione | Fine |
|---|---|---|
| VERASTEM, INC. | Direttore Tecnico/Scientifico/R&S | 20/01/2021 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - |
Formazione di Frank Neumann
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
| University of Bonn | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Frank Neumann
